Terence Wong earned his Ph.D. in Biological and Biomedical Sciences from Harvard University and Broad Institute of MIT and Harvard, where he integrated large functional genomic datasets to identify and characterize novel genetic vulnerabilities in cancer. He is currently the Precision Oncology Medical Strategy, Therapy Selection Lead at Exact Sciences, where he develops and manages the comprehensive and integrated medical strategy for Exact's Therapy Selection products. Prior to Exact, he was a Strategy Insights & Planning Associate Consultant at ZS Associates, where he delivered innovative solutions to pipeline and launch strategy challenges for clients in the oncology biopharma and diagnostics industry. Prior to ZS, he was a Clinical Genomics Analyst at Rady Children's Institute for Genomic Medicine (RCIGM), where he analyzed whole genome sequencing data to identify genetic causes for rare disease in critically ill infants and children. He has recently published in the fields of clinical genetics and precision medicine, and is passionate about genetics education.